Opentrons, Pandemic Response Lab

As we enter the third year of the COVID-19 pandemic, we recognize that although the pandemic isnt over, it has transitioned into a new phase. In light of a rapidly changing external environment, we have made the difficult decision to wind down operations for PRL effective 12/31/22 and make a strategic pivot to center our lab services on non-clinical lab customers. This shift points our company to areas where we can make the most significant impact in the most differentiated way. We will no longer be accepting samples after 12/27 and will reassign our sequencing core and biosurveillance activities to...

Respiratory panels,infectious disease panels,sti panels,gi panels,thyroid panels,covid panels,sequencing,low-cost,<24 hour turn around,high quality,and testing labs across the u.s.

Opentrons, pandemic response lab operates in the Biotechnology research industry.

Opentrons, pandemic response lab's revenue is 11m - 100m

Opentrons, pandemic response lab has 11 - 50 employees.